Craniofacial Cavernous Venous Malformations: Percutaneous Sclerotherapy with Use of Ethanolamine Oleate

2002 ◽  
Vol 13 (5) ◽  
pp. 475-482 ◽  
Author(s):  
Young Ho Choi ◽  
Moon Hee Han ◽  
Kwon O-Ki ◽  
Sang Hoon Cha ◽  
Kee-Hyun Chang
Keyword(s):  
Venous Malformations ◽  
Ethanolamine Oleate ◽  
Percutaneous Sclerotherapy

Percutaneous sclerotherapy with ethanolamine oleate for venous malformations of the head and neck

2013 ◽  
Vol 6 (9) ◽  
pp. 695-698 ◽  
Author(s):  
Matthew David Alexander ◽  
Ryan A McTaggart ◽  
Omar A Choudhri ◽  
Mary L Marcellus ◽  
Huy M Do
Keyword(s):  
Head And Neck ◽  
Venous Malformations ◽  
Ethanolamine Oleate ◽  
Percutaneous Sclerotherapy

Real-time MRI-guided percutaneous sclerotherapy treatment of venous low-flow malformations in the head and neck

2017 ◽  
Vol 33 (5) ◽  
pp. 344-352 ◽  
Author(s):  
Sasan Partovi ◽  
Ziang Lu ◽  
Lorenna Vidal ◽  
Dean A Nakamoto ◽  
Ji Buethe ◽  
...  
Keyword(s):  
Head And Neck ◽  
Real Time ◽  
Low Flow ◽  
Venous Malformations ◽  
Needle Placement ◽  
Ethanolamine Oleate ◽  
Percutaneous Sclerotherapy ◽  
Institutional Experience ◽  
Mri Guided ◽  
Truefisp Sequence

Purpose This manuscript describes the technique of real-time MRI-guided sclerotherapy for low-flow venous malformations in the head and neck based on our institutional experience. Materials and methods Ethanolamine oleate is used as the sclerosant and is mixed with gadolinium for visualization during the procedure. The five procedural steps include: (I) an initial tri-plane T2-weighted sequence to visualize the lesion; (II) a T1 FSE or trueFISP sequence to assess needle placement and advancement within the lesion; (III) a tri-plane T1 FLASH sequence to monitor sclerosant injection; (IV) a T1 FSE or VIBE sequence to assess sclerosant coverage of the malformation before needle removal; (V) a post-procedural tri-plane T1 fat-saturated sequence to confirm sclerosant coverage of the lesion. Periprocedural medications typically include steroids, antibiotic prophylaxis, and non-steroidal anti-inflammatory medication. Patients are typically admitted for overnight observation. Conclusion Real-time MRI-guided sclerotherapy for low-flow venous malformations in the head and neck is effective and safe.

Percutaneous sclerotherapy for spongiform venous malformations – analysis of patient-evaluated outcome and satisfaction

VASA ◽  
2017 ◽  
Vol 46 (6) ◽  
pp. 477-483
Author(s):  
Robert Karl Clemens ◽  
Frederic Baumann ◽  
Marc Husmann ◽  
Thomas Oleg Meier ◽  
Christoph Thalhammer ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Medical Records ◽  
Venous Malformation ◽  
Primary Treatment ◽  
Venous Malformations ◽  
Treated Area ◽  
Item Questionnaire ◽  
Percutaneous Sclerotherapy ◽  
Multiple Treatments ◽  
Pain Improvement

Abstract. Background: Congenital venous malformations are frequently treated with sclerotherapy. Primary treatment goal is to control the often size-related symptoms. Functional impairment and aesthetical aspects as well as satisfaction have rarely been evaluated. Patients and methods: Medical records of patients who underwent sclerotherapy of spongiform venous malformations were reviewed and included in this retrospective study. The outcome of sclerotherapy as self-reported by patients was assessed in a 21 item questionnaire. Results: Questionnaires were sent to 166 patients with a total of 327 procedures. Seventy-seven patients (48 %) with a total of 159 procedures (50 %) responded to the survey. Fifty-seven percent of patients were male. The age ranged from 1 to 38.1 years with a median age of 16.4 years. The lower extremities were the most common treated area. Limitations caused by the venous malformation improved in the majority of patients (e.g. pain improvement 87 %, improvement of swelling 83 %) but also worsening of symptoms occurred in a minority of cases. Seventy-seven per cent would undergo sclerotherapy again. Conclusions: Sclerotherapy for treatment of venous malformations results in significant reduction of symptoms. Multiple treatments are often needed, but patients are willing to undergo them.

Percutaneous Sclerotherapy for Congenital Venous Malformations in the Extremities

Orthopedics ◽  
2001 ◽  
Vol 24 (1) ◽  
pp. 45-51
Author(s):  
Yuki Yao ◽  
Nick N T Lomis ◽  
Steven M Scott ◽  
Hyo-Chun Yoon ◽  
Franklin J Miller
Keyword(s):  
Venous Malformations ◽  
Percutaneous Sclerotherapy

scholarly journals Preoperative Cyanoacrylate Embolization of Venous Malformations

2018 ◽  
Vol 02 (01) ◽  
pp. 042-050 ◽  
Author(s):  
Eric Monroe ◽  
Rush Chewning ◽  
Kevin Koo ◽  
Giri Shivaram
Keyword(s):  
Blood Loss ◽  
Surgical Margin ◽  
Surgical Excision ◽  
High Volume ◽  
Definitive Treatment ◽  
Incomplete Resection ◽  
Venous Malformations ◽  
Cyanoacrylate Glue ◽  
Multiple Treatment ◽  
Percutaneous Sclerotherapy

AbstractPercutaneous sclerotherapy and standalone surgical excision have historically been the mainstay of treatment for pediatric venous malformations (VMs). However, both approaches have significant limitations. Sclerotherapy often requires multiple treatment sessions, with each round adding additional procedural and anesthetic risks as well as radiation exposure. Standalone surgical excision of VMs can be complicated by high-volume blood loss, and indistinct lesion margins can lead to incomplete resection, resulting in recurrence. An alternative to these approaches is percutaneous cyanoacrylate glue embolization followed by immediate surgical excision, a single-stage procedure that allows for better surgical margin definition and reduced intraoperative blood loss, potentially leading to more definitive treatment. The authors describe the interventional radiology aspects of this combined procedure, emphasizing materials preparation and embolization technique.

scholarly journals Risk Factors for Macroscopic Haemoglobinuria After Sclerotherapy Using Ethanolamine Oleate for Venous Malformations

2019 ◽  
Vol 58 (1) ◽  
pp. 105-111
Author(s):  
Masahide Fujiki ◽  
Mine Ozaki ◽  
Isao Kurachi ◽  
Yuki Iwashina ◽  
Akihiko Takushima
Keyword(s):  
Risk Factors ◽  
Venous Malformations ◽  
Ethanolamine Oleate

scholarly journals Therapeutic evaluation of sclerotherapy for limb venous malformations: A case series

2020 ◽  
Vol 35 (9) ◽  
pp. 663-671
Author(s):  
Tenghui Zhan ◽  
Fanggang Cai ◽  
Pingfan Guo ◽  
Yujie Lian ◽  
Hui Zhuang ◽  
...  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Doppler Ultrasound ◽  
Clinical Examination ◽  
Clinical Manifestations ◽  
Case Series ◽  
Venous Malformations ◽  
Resonance Imaging ◽  
Percutaneous Sclerotherapy

Objectives To examine three different methods for evaluating the effect of percutaneous sclerotherapy on limb venous malformations in a series of patients with a relatively long follow-up. Method The study was a retrospective study. Results Thirty-eight patients treated with percutaneous sclerotherapy underwent sclerotherapy, with a median number of sessions of 4 (range, 1–10). They were followed up for 1–60 months (average 12.5 months). The kappa between clinical manifestations and Doppler ultrasound was 0.684 ( P < 0.001). The kappa between clinical manifestations and magnetic resonance imaging was 0.217 ( P = 0.006). The kappa between Doppler ultrasound and magnetic resonance imaging was 0.323 ( P < 0.001). The rate of grade IV patients evaluated by clinical manifestations was significantly higher than that by Doppler ultrasound and magnetic resonance imaging. Conclusions Magnetic resonance imaging is the gold standard for VM imaging. Its consistency with clinical examination and Doppler ultrasound is poor, and Doppler ultrasound and clinical examination could be more appropriate for follow-up imaging after sclerotherapy.

Sign in / Sign up

Export Citation Format

Share Document